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           During the infl  ammatory response, leukocytes 
leave the bloodstream and cross the endothelium 
to reach infl  amed tissue. Leukocyte extravasa-
tion is known to involve a well-characterized 
sequence of rolling, activation, and fi  rm adhe-
sion followed by locomotion to the endothelial 
junction, where leukocytes squeeze between 
adjacent cells in an ameboid fashion across the 
endothelial borders via a process called diape-
desis (  Butcher, 1991  ;   Springer, 1994  ;   Muller, 
2002  ). Platelet/endothelial cell adhesion mol-
ecule (PECAM; CD31), CD99, and junctional 
adhesion molecule A (JAM-A) are molecules 
shown to mediate the migration of leukocytes 
across endothelial cell junctions (  Muller, 2003  ; 
  Ley et al., 2007  ;   Muller, 2009  ). 
  Although it is well accepted that leukocytes 
cross the endothelium at the cell borders (para-
cellular route), there is increasing evidence that 
leukocytes can also pass directly through endo-
thelial cells (transcellular route). Much of the 
original evidence was indirect, based on single 
transmission electron micrographs that appeared 
to show leukocytes deeply indenting endothe-
lial cells and/or passing across endothelial cells 
through a membrane-lined channel next to an 
intact junction (  Williamson and Grisham, 1961  ; 
  Marchesi and Gowans, 1964  ;   Bamforth et al., 
1997  ). However, endothelial junctions are ser-
pentine, and it was possible that the leukocyte 
was passing through a less structured junction 
(  Muller, 2001  ). Recently, several in vitro mod-
els were established that produced reliable tran-
scellular migration (  Carman and Springer, 2004  ; 
  Yang et al., 2005  ;   Millán et al., 2006  ). Despite the 
progress made in uncovering some of the mole-
cules involved in the transcellular route of dia-
pedesis, it remains unclear why leukocytes that 
appear to use the same mechanisms for rolling and 
adhesion will transmigrate through the endothe-
lial cell rather than at the junctions. Understand-
ing the mechanisms underlying transcellular 
diapedesis will help answer this question. 
  In our previous studies, we showed that 
PECAM at the borders of endothelial cells en-
ters a novel membrane compartment connected 
to the cell surface at the cell borders (  Mamdouh 
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  Leukocyte migration across endothelial cell borders (paracellular) and through endothelial 
cells (transcellular) appear to be distinct processes. During paracellular migration, membrane 
from a parajunctional reticulum of interconnected vesicles, the endothelial lateral border 
recycling compartment (LBRC), moves to surround the leukocyte in a kinesin-mediated, 
microtubule-dependent manner. We show that transcellular migration likewise requires 
targeted traffi  cking of LBRC membrane. We show that in addition to platelet/endothelial 
cell adhesion molecule (PECAM; CD31), CD99 and junctional adhesion molecule A (JAM-A), 
but apparently not vascular endothelial cell–specifi  c cadherin (cadherin 5, CD144), are 
components of the LBRC. During transcellular migration, LBRC membrane invests the trans-
migrating leukocyte. Intracellular adhesion molecule 1 (ICAM-1) on the apical endothelial 
surface is enriched around adherent leukocytes. Depolymerization of microtubules has no 
effect on ICAM-1 enrichment but blocks targeted traffi  cking of LBRC membrane and trans-
cellular migration by >90%. Similar to their effects on paracellular transmigration, antibod-
ies against PECAM or CD99, but not JAM-A, block transcellular migration. We conclude 
that similar molecular mechanisms promote both para- and transcellular migration. 
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transmigration was stopped at 10 min, up to 10% of leuko-
cytes were caught in the act of transcellular migration. If the 
interaction was allowed to continue for 30 min,     30% of 
monocytes had migrated transcellularly. 
  Because PECAM-1 is a key player in leukocyte paracel-
lular diapedesis, we wondered whether it had any role in 
transcellular diapedesis. To test this, we allowed monocytes 
or neutrophils to cross TNF-activated human umbilical vein 
endothelial cell (HUVEC) monolayers in the presence of ex-
ogenous MCP-1 or fMLP to stimulate transcellular migration 
as described, but stained for PECAM. As shown in   Fig. 1  , 
PECAM, which is normally expressed at the borders of endo-
thelial cells, is now also found in the center of the cell sur-
rounding the crossing leukocytes. Note that although PECAM 
is expressed on the surfaces of monocytes and neutrophils, its 
concentration is 10–20 times lower than on endothelial cells 
and is not detected on leukocytes at this level of sensitivity. 
Note the absence of staining on leukocytes not crossing the 
endothelial cell (asterisks). Other junctional molecules such as 
CD99 and JAM-A, which have also been shown to be key 
players in the paracellular diapedesis step, also formed rings 
that surrounded the crossing leukocyte (  Fig. 1  ). These data 
strongly suggest that PECAM, CD99, and JAM-A are involved 
in the transcellular route of leukocyte diapedesis. In contrast, 
when we examined the localization of VE-cadherin during 
monocyte transcellular diapedesis, it remained along the en-
dothelial border and was absent from the site of transcellular 
migration. This result suggests that VE-cadherin is not in-
volved in leukocyte transcellular diapedesis (  Fig. 1  ). 
  A previous study provided evidence that ICAM-1 was re-
cruited into caveolae, which were relatively enriched at the 
site of transcellular migration (  Millán et al., 2006  ), although 
others studying the same phenomenon found caveolae to be 
only partially (  Carman and Springer, 2004  ) or not enriched 
(  Carman et al., 2007  ). Similar to the latter study, we rarely de-
tected caveolin-1 staining around leukocytes migrating trans-
cellularly. When we did, however, the staining was weak and 
clearly outside the zone of PECAM staining that encircled the 
transmigrating leukocyte (  Fig. 2  ).   Because there was no over-
lap of the green and red fl  uorescence (  Fig. 2  , inset), the mem-
branes bearing PECAM and caveolin-1 should be at least 200 nm 
(approximately four caveolae diameters) apart. 
  CD99 and JAM-A, but not VE-cadherin, are in the LBRC 
  The unexpected presence of molecules from the lateral cell 
border (PECAM, JAM-A, and CD99) on the apical surface of 
the endothelial cell surrounding the leukocyte raised the 
question of how they got there. We previously described the 
LBRC, a novel membrane compartment in endothelial cells 
that is made of vesicle-like structures connected to each other 
and to the cell surface at the borders. 30% of total endothelial 
PECAM constitutively cycles between this compartment and 
the surface at the borders (  Mamdouh et al., 2003  ;   Mamdouh 
et al., 2008  ). Moreover, we showed that paracellular diapede-
sis of both monocytes, lymphocytes, and neutrophils requires 
mobilization of PECAM-containing membrane from the 
et al., 2003  ). It is quite distinct from typical recycling endo-
somes, caveolae, and vesiculo-vacuolar organelles (  Feng et al., 
1996  ;   Mamdouh et al., 2003  ). We called this interconnected 
reticulum of membrane the lateral border recycling compart-
ment (LBRC;   Mamdouh et al., 2008  ). Membrane from this 
compartment was found to cycle constitutively between the 
LBRC and the cell surface evenly along the borders of resting 
endothelial cells. When a leukocyte crosses the endothelial 
cell junction, the LBRC membrane is mobilized to the sur-
face of the junction at the site of diapedesis and surrounds the 
leukocyte (  Mamdouh et al., 2003  ;   Mamdouh et al., 2008  ). 
This targeted recycling of LBRC membrane to the site of dia-
pedesis is mediated by kinesin molecular motors along micro-
tubules, and is required for paracellular diapedesis of all classes 
of leukocytes, even under conditions where transmigration 
could not be blocked by anti-PECAM mAb (  Mamdouh 
et al., 2008  ). We hypothesized that this targeted recycling 
would provide more membrane surface area and unligated 
PECAM to facilitate leukocyte passage (  Mamdouh et al., 2003  ; 
  Mamdouh et al., 2008  ). 
  In this paper, we report that transcellular diapedesis of 
monocytes and neutrophils across human endothelial cells 
involves traffi   cking of the LBRC to the site of transcellular 
diapedesis. We also show that in addition to PECAM, the 
LBRC contains CD99 and JAM-A but not vascular endothe-
lial cell–specifi  c cadherin (VE-cadherin; cadherin 5, CD144). 
Similar to paracellular migration, traffi   cking of the LBRC in 
transcellular migration is microtubule dependent. Transcel-
lular migration is likewise dependent on PECAM and CD99. 
We conclude that trans- and paracellular leukocyte migration 
involve similar mechanisms. 
  RESULTS 
  Transcellular migration recruits molecules normally found 
at the endothelial cell border 
  In our in vitro transmigration assay, under normal conditions 
of cytokine activation, almost all leukocytes cross the endo-
thelial cells at the cell borders (i.e., paracellular migration). 
However, if we created a gradient of monocyte chemotactic 
protein 1 (MCP-1; CCL2) or fMLP by injecting 10 μl into 
the collagen gel underlying the endothelial monolayer, a 
substantial fraction of monocytes and neutrophils, respec-
tively, crossed the monolayer by passing through the endo-
thelial cells (i.e., transcellular migration). Monolayers were 
fi  xed within 10 min of cellular interaction to catch leuko-
cytes in the act of transmigration. Cells were gently permea-
bilized and stained for intracellular adhesion molecule 1 
(ICAM-1) and actin (to visualize the cellular interaction). As 
others have reported previously (  Carman and Springer, 2004  ; 
  Yang et al., 2005  ;   Millán et al., 2006  ), we also found that 
transcellular migration of monocytes is concomitant with an 
enrichment of ICAM-1 around the crossing cells (  Fig. 1  ).   
ICAM-1 was not only enriched at the luminal surface of en-
dothelial cells at the site of transcellular diapedesis but fol-
lowed the leukocyte as it crossed the endothelial cell body 
and formed a channel around it (  Fig. 1  , XZ insets). When JEM VOL. 206, November 23, 2009 
Article
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    Figure 1.     Enrichment of endothelial cell adhesion molecules around leukocytes migrating transcellularly.   Representative confocal or decon-
volved images of monocytes or PMNs caught in the act of transcellular migration are shown stained with mAbs for the indicated cell adhesion molecule 
(CAM; green in merge), phalloidin to mark actin (red in merge), and DAPI to mark nuclei (blue in merge). Rings of enrichment of ICAM-1, PECAM, CD99, 
and JAM-A were consistently seen surrounding the site at which leukocytes migrated through the endothelial cell (arrows; left). Each event was verifi  ed 
by scanning through the monolayer. Orthogonal (XZ) projections along the plane indicated by the white line (XZ) shown below the merged images dem-
onstrate that the leukocyte was indeed crossing the endothelial cell (arrows; right). The thin white line underlies the basal surface of the endothelial cell. 
The JAM-A panels show a monocyte (top) and a PMN (bottom). Note in the PECAM panel and top JAM-A panel that several leukocytes are present on the 
endothelial cell but only the site of transcellular migration stains for PECAM or JAM-A, respectively, demonstrating that the PECAM and JAM-A stained 
around the leukocyte belongs to the endothelial cell. Asterisks indicate leukocytes not in the act of transmigration and not stained for PECAM or JAM-A. 
Arrows in the PECAM and VE-cadherin panels point to the site of transcellular migration where endothelial cell actin is pushed aside. Arrowheads mark 
cell borders. Data are representative of hundreds of transmigration events recorded in 3–10 independent experiments for each marker. Bars, 10 μm.     2798 Trans- and paracellular migration share common mechanism   | Mamdouh et al. 
  Targeted movement of LBRC membrane to the site 
of transcellular migration 
  Because PECAM, CD99, and JAM-A, but not VE-cadherin, 
were recruited to the site of transcellular migration, we hy-
pothesized that the LBRC might be recruited to surround 
the leukocyte in a similar manner to the way it is recruited 
to surround leukocytes undergoing paracellular diapedesis 
(  Mamdouh et al., 2003  ;   Mamdouh et al., 2008  ). The facts 
that the LBRC does not contain caveolin-1 (  Mamdouh et al., 
2003  ) nor appears to contain VE-cadherin (  Fig. 3  ) and that 
neither was enriched around the transmigrating leukocyte 
(  Figs. 1   and   2  ) were also consistent with this hypothesis. We 
next investigated whether there was targeted traffi   cking of 
LBRC membrane to the site of transcellular migration using 
recycling PECAM as a surrogate tracer of LBRC. In this ex-
periment, we used a nonblocking Fab fragment to trace the 
recycling of LBRC during leukocyte diapedesis, as described 
previously (  Mamdouh et al., 2003  ;   Mamdouh et al., 2008  ). 
  Fig. 4   shows Z-series confocal projections of representative 
images in which a monocyte (top) and a neutrophil (bottom) 
are crossing an endothelial cell far from the junctions, as 
shown in the XZ insets.   Traffi   cking of LBRC membrane 
was detected at the site of leukocyte transcellular diapedesis 
in virtually every migration event we could document. The 
intensity of recycled PECAM at the diapedesis site was clearly 
higher than PECAM at the junctions (the latter represents 
constitutive recycling of LBRC membrane evenly along the 
endothelial borders that we have previously demonstrated 
takes place independently of leukocytes;   Mamdouh et al., 
2003  ;   Mamdouh et al., 2008  ). These data suggest that trans-
cellular migration, like paracellular diapedesis, involves a 
similar mechanism of LBRC membrane recruitment to the 
site of diapedesis. Because CD99 and JAM-A were also seen 
in an intracellular compartment structurally and functionally 
resembling the LBRC and were also recruited to the site of tran-
scellular diapedesis, we speculate that leukocyte transcellular 
LBRC to the site of the junction where leukocytes are cross-
ing (  Mamdouh et al., 2008  ). We wondered whether the other 
junctional molecules that surrounded the leukocyte during 
the transcellular diapedesis also originate from the LBRC. 
We examined the localization of CD99, JAM-A, and VE-
cadherin by immunoelectron microscopy (immuno-EM). 
  Fig. 3   shows representative en face sections (i.e., cut in a plane 
parallel to the culture dish) of HUVEC monolayers labeled 
at 37°C with mAbs against PECAM, CD99, JAM-A, or 
VE-cadherin.   Positive staining of PECAM, CD99, JAM-A, 
and VE-cadherin was seen, as expected, at the junction of 
HUVECs. More important, 50-nm vesicle-like structures 
connected to each other and to the cell surface appearing 
morphologically similar to the PECAM-containing LBRC 
were also seen labeled with anti-CD99 and anti–JAM-A anti-
bodies. Moreover, these molecules were shown to be in the 
LBRC functionally, because they underwent constitutive re-
cycling with the same time course as PECAM (unpublished 
data;   Mamdouh et al., 2003  ;   Mamdouh et al., 2008  ). However, 
despite examination of hundreds of cell profi  les, such struc-
tures were never seen to be stained with anti–VE-cadherin 
antibody, even though VE-cadherin was detected in the junc-
tions between HUVECs. These data suggest that the LBRC 
contains CD99 and JAM-A in addition to PECAM, but not 
VE-cadherin. This hypothesis was confi  rmed by ablation ex-
periments (  Ghosh et al., 1998  ;   Lampson et al., 2001  ), which 
are based on quenching of Alexa Fluor 488 fl  uorescence by 
products of the horseradish peroxidase (HRP), 3,3    -diamino-
benzidine (DAB), and H  2  O  2   reaction. When HUVECs were 
incubated with Alexa Fluor 488–anti-CD99 and HRP–anti-
PECAM, and then exposed to a mixture of DAB and H  2  O  2  , 
Alexa Fluor 488 fl   uorescence was completely quenched 
(99%), whereas the endocytic marker, HRP-transferrin, had 
no eff  ect on Alexa Fluor 488–anti-CD99 fl  uorescence (un-
published data). The same results were seen when the HRP 
and Alexa Fluor labels were switched. 
    Figure 2.     Caveolae do not comprise the membrane that forms the transmigration pore.   Leukocytes  fi  xed in the act of transcellular migration 
were stained for caveolin-1 (red in merge), PECAM (green in merge), and DNA to label nuclei (blue in merge). PECAM forms a defi  nite ring around the 
leukocyte (arrow), as seen in   Fig. 1  . In this image, several vesicular structures staining for caveolin-1 are seen distributed in a circular fashion around the 
transmigrating leukocyte as well (arrow). However, when the images are overlapped (merge), it is clear that the caveolin-1 staining is peripheral to and 
not overlapping with the PECAM staining. (inset) An enlargement of the transmigration pore displaying just the caveolin-1 and PECAM staining for 
clarity. In the inset, the brightness of the caveolin-1 staining was artifi  cially raised to enable better visualization of caveolin-1. Data are representative 
of three independent experiments. Bar, 10 μm.     JEM VOL. 206, November 23, 2009 
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or intermediate fi  lament distribution, or monolayer permea-
bility over the course of the experiment (  Mamdouh et al., 
2008  ). Controls run with each experiment verifi  ed the eff  ec-
tiveness of DCN treatment and the integrity of the endothe-
lial monolayers (  Mamdouh et al., 2008  ). Transendothelial 
migration (TEM) in this experiment was performed for a 
short period of time (10 min), which enabled us to catch leu-
kocytes in the act of diapedesis. We stained the cells with Al-
exa Fluor 488–phalloidin to visualize both endothelial cells 
and leukocytes and the junctions with Alexa Fluor 546–anti–
VE-cadherin. Hundreds of fi  elds were examined by confocal 
microscopy to quantify the number of monocytes crossing 
the endothelial cell at the junctions and far from them (  Fig. 5 a  ).   
Under these conditions, in control cells most monocytes 
were crossing the monolayer at the cell borders; however, 
    13% of cells undergoing diapedesis were taking the trans-
cellular route. Consistent with previous data (  Mamdouh 
et al., 2008  ), DCN treatment blocked paracellular diapedesis 
by 75%. The same treatment blocked transcellular diapedesis 
almost completely (>90% block). 
  These data show that intact microtubules are as critical for 
transcellular diapedesis as they are for the paracellular pathway. 
Moreover, dissolution of microtubules abolished the targeted 
traffi   cking of LBRC membrane to the site of transcellular dia-
pedesis (  Fig. 5 b  ) just as it abolishes the targeted recycling of 
LBRC membrane to the cell border in paracellular diapedesis 
(  Mamdouh et al., 2008  ). In the absence of functional micro-
tubules, there is no targeted traffi   cking of LBRC membrane 
and no transmigration, either paracellularly or transcellularly. 
  Transcellular migration requires PECAM and CD99 
  Paracellular transmigration of human neutrophils and mono-
cytes, which requires targeted recycling of LBRC membrane 
(  Mamdouh et al., 2003  ;   Mamdouh et al., 2008  ), can be 
diapedesis involves the recruitment of membrane from the 
LRBC that contains not only PECAM but also CD99 and 
JAM-A. VE-cadherin, which is excluded from the LBRC, is 
absent from the site of leukocyte transcellular diapedesis 
(  Fig. 1  ), as it is in the paracellular pathway (  Allport et al., 
2000  ;   Shaw et al., 2001  ). 
  The targeted traffi   cking assay that we have used to docu-
ment LBRC movement in paracellular migration (  Mamdouh 
et al., 2003  ;   Mamdouh et al., 2008  ) and transcellular migra-
tion (  Fig. 4  ) is a functional assay. The transmigration takes 
place while the cells are incubated in fl  uorescently labeled 
secondary antibody. Membrane from the LBRC becomes 
labeled only when it reaches the surface of the cell. Mono-
layers are washed and fi  xed before microscopic examination. 
The rings of fl  uorescence around the leukocyte represent 
membrane from the LBRC in contact with the leukocyte at 
the time of fi  xation. 
  These data collectively support the idea that both the para- 
and transcellular routes involve similar mechanisms. They both 
involve targeted recycling of LBRC membrane containing 
PECAM, CD99, and JAM-A, but not VE-cadherin, to the 
site of diapedesis. We have recently shown that microtubules 
and kinesins are critical for targeted recycling of the LBRC 
and thus for leukocyte paracellular migration (  Mamdouh 
et al., 2008  ). If the same mechanisms apply to trans- and para-
cellular transmigration, microtubules would also be required 
for guiding LBRC traffi   cking for the transcellular route. We 
pretreated HUVEC monolayers with 10 μM demecolcine 
(DCN; colcemide) for 1 h as previously described (  Mamdouh 
et al., 2008  ), washed monolayers free of drug, and examined 
transcellular migration of monocytes in control and DCN-
treated cells. This treatment was shown to reproducibly de-
polymerize microtubules without aff  ecting endothelial cell 
adhesion molecule distribution, calcium signaling, actin 
    Figure 3.     CD99 and JAM-A, but not VE-cadherin, are in the LBRC.   Endothelial cells were incubated with HRP-conjugated mAbs specifi  c for 
PECAM, CD99, JAM-A, or VE-cadherin for 1 h at 37°C, and were fi  xed and reacted with diaminoabenzidine-H  2 O 2   as previously described (  Mamdouh et al., 
2003  ). As a control for nonspecifi  c labeling, free HRP was added at the concentration present on the antibodies (5.5 μM). En face sections were cut for 
electron microscopic analysis. Images shown are representative of at least 100 cell profi  les taken from at least two independent experiments. In addition 
to being present along the cell border (dark electron-dense staining), PECAM is present in interconnected vesicular structures of the LBRC, as previously 
described (  Mamdouh et al., 2003  ), as are CD99 and JAM-A. VE-cadherin is present at the cell borders (arrowhead) but not in the interconnected vesicular 
structures of the LBRC adjacent to it (arrows). Bars, 200 nm.     2800 Trans- and paracellular migration share common mechanism   | Mamdouh et al. 
paracellular diapedesis. In pilot experiments, the block in 
transcellular migration was confi  rmed by live-cell imaging 
using diff  erential interference contrast optics (  Schenkel et al., 
2004  ;   Lou et al., 2007  ). 
  Finally, we wished to understand the relative timing of the 
involvement of ICAM-1, an apical surface molecule, and 
molecules within the LBRC in transcellular migration. Clus-
tering of ICAM-1 has been observed to precede paracellular 
migration (  Shaw et al., 2004  ) and be important for transcellu-
lar migration (  Yang et al., 2005  ). Would disruption of micro-
tubules aff  ect the clustering of ICAM-1, or is it independent 
and/or “upstream” of this process? We performed a recycling 
experiment as previously described using PECAM as a tracer 
for the LBRC (  Mamdouh et al., 2003  ;   Mamdouh et al., 2008  ) 
in control and DCN-treated cells. We fi  xed the cells and 
stained them for ICAM-1. Representative images are shown 
in   Fig. 7  .   In a typical control monolayer, the z-series confocal 
projection showed a monocyte crossing the middle of an en-
dothelial cell, as shown in the XZ inset. PECAM and ICAM-
1 are both enriched around the crossing monocytes, consistent 
with the data shown in   Fig. 1  . In DCN-pretreated cells, the 
LBRC cannot move to the site of leukocyte migration; con-
sequently, monocytes are blocked and cannot cross the body 
of endothelial cells. The ring of ICAM-1 around these mono-
cytes indicates that they are actively engaged with the endo-
thelial cell. However, despite robust enrichment of ICAM-1 
blocked by mAbs against PECAM and CD99 but not JAM-A 
(  Muller et al., 1993  ;   Liu et al., 2000  ;   Schenkel et al., 2002  ; 
  Schenkel et al., 2004  ). This raised the question of whether 
transcellular migration similarly could be blocked by these 
antibodies. Transmigration assays were performed in the 
presence of antibodies against PECAM, CD99, JAM-A, or 
VE-cadherin and examined by confocal microscopy, scoring 
for leukocytes that had undergone para- or transcellular dia-
pedesis (  Fig. 6  ).   To be able to distinguish leukocytes blocked 
in the act of transmigration from those that were actually 
going through (especially for CD99, which arrests leuko-
cytes part way through the junction;   Schenkel et al., 2002  ; 
  Lou et al., 2007  ), we ran the transmigration assay for 30 min 
to allow ample time for unblocked leukocytes to move across 
the endothelial monolayer. As a result, the control transmi-
gration rate was     80%, with up to 33% of the leukocytes 
migrating transcellularly (compare with the 10-min assay in 
  Fig. 4   in which only     45% of control leukocytes transmi-
grated.) As previously reported, paracellular diapedesis was 
eff  ectively blocked (by     75% compared with control) by 
antibody against PECAM or CD99 but not against JAM-A 
or VE-cadherin (  Muller et al., 1993  ;   Liu et al., 2000  ;   Schenkel 
et al., 2002  ;   Schenkel et al., 2004  ). Interestingly, transcellular 
diapedesis was also blocked by antibody against PECAM or 
CD99 but not against JAM-A or VE-cadherin, and transcel-
lular diapedesis was inhibited to about the same extent as was 
    Figure 4.     Targeted traffi  cking of membrane from the LBRC to surround leukocytes undergoing transcellular migration.   PECAM in the LBRC 
was labeled with Fab fragments of a nonblocking mAb as a surrogate marker for LBRC traffi  cking to the endothelial surface, as previously described 
(see Materials and methods;   Mamdouh et al., 2003  ;   Mamdouh et al., 2008  ). Staining of recycled PECAM (Rec PECAM; red in merge) surrounding mono-
cytes (top) and a PMN (bottom) demonstrates movement of membrane from the LBRC to the endothelial surface. Recycled PECAM is seen around the 
leukocytes migrating transcellularly (small arrows) far from the endothelial border (arrowheads). Recycling LBRC enrichment is as great around the 
monocyte migrating transcellularly as it is around the monocyte migrating paracellularly (large arrow). Actin staining (green in merge) shows relative 
positions of the cells. Orthogonal (XZ) projection demonstrates leukocytes in the act of transcellular migration. Arrows (right) indicate recycled PECAM 
around leukocytes. The asterisk indicates an endothelial cell nucleus. These images are representative of >200 transcellular migration events captured 
in >12 independent experiments. Bars, 10 μm.     JEM VOL. 206, November 23, 2009 
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73 ± 5.6% of monocytes were surrounded by rings of both 
ICAM-1 and recycled PECAM. Most monocytes that were 
surrounded only by ICAM-1 were on the apical surface and 
had not penetrated the endothelial cell, whereas most 
monocytes surrounded only by a ring of recycled PECAM 
had almost completed transcellular migration (unpublished 
data). This suggested that virtually every monocyte caught 
in the more advanced stages of diapedesis was surrounded 
by a ring of recycled PECAM. In contrast, when microtu-
bules were depolymerized and monocytes could not trans-
migrate, 90 ± 6% of leukocytes were surrounded only by a 
around the leukocyte, in the absence of targeted traffi   cking 
from the LBRC, transcellular migration did not occur. These 
data are representative of hundreds of interactions on 50 indi-
vidual co-cultures in fi  ve independent experiments. 
  To quantify these data in an objective way, we exam-
ined all monocytes interacting with the endothelial mono-
layer in these experiments. Because it was diffi   cult  to 
determine whether a leukocyte deeply indenting the apical 
surface of the endothelial cell was in the process of transmi-
gration, we scored any monocyte with a ring of either 
ICAM-1 or recycled PECAM. In the control monolayers, 
    Figure 5.     Depolymerizing microtubules blocks transcellular migration and targeted traffi  cking of the LBRC.   (a) Endothelial monolayers were 
treated with DMSO carrier (Contr) or DCN under conditions that selectively and reproducibly depolymerized only endothelial microtubules (  Mamdouh et al., 
2008  ). Monocytes were allowed to transmigrate for 10 min, and the monolayers were then fi  xed and stained for VE-cadherin to mark cell junctions and 
phalloidin to stain actin. The number of adherent cells undergoing paracellular (Para) or transcellular (Trans) migration was scored as described in Materi-
als and methods. Because this was an early time point, designed to catch leukocytes at the site of their transmigration, the absolute levels were not yet 
maximal. Paracellular transmigration was blocked by >75% by microtubule depolymerization, as expected (  Mamdouh et al., 2008  ), and transcellular migra-
tion was blocked by >90%. Values are means ± SEM derived from observations of a total of 1,418 leukocytes on control monolayers and 1,690 leukocytes 
on DCN-treated monolayers in fi  ve independent experiments. *, P = 0.000304 for paracellular transmigration; **, P = 0.00092 for transcellular migration. 
(b) Targeted traffi  cking of LBRC membrane was visualized in similarly treated monolayers using anti-CD11b to visualize the leukocytes. A ring of LBRC 
membrane surrounds the leukocyte undergoing transcellular migration in the control monolayer, as seen in   Fig. 4  . (inset) A leukocyte clearly migrating 
transcellularly. However, in DCN-treated monolayers (bottom), monocytes adhere (*) but no targeted traffi  cking of LBRC membrane is seen. Arrowheads 
show endothelial cell borders marked by constitutive recycling. The thin white line in the orthogonal projection indicates the abluminal surface of endo-
thelial cells. The arrow indicates the portion of leukocytes below the endothelium. Data are representative of fi  ve independent experiments. Bar, 10 μm.     2802 Trans- and paracellular migration share common mechanism   | Mamdouh et al. 
transcellular migration of myeloid cells are also dependent on 
PECAM and CD99 (  Fig. 6  ). 
  Our data clearly show that membrane from the LBRC 
surrounds leukocytes migrating transcellularly. We are pres-
ently unable to directly demonstrate how it gets there. Be-
cause of technical limitations, we cannot satisfactorily resolve 
targeted recycling of LBRC membrane in living cells in real 
time. However, we favor the idea that, as in the case of 
paracellular transmigration, LBRC membrane is targeted to 
the site of transmigration in a microtubule-dependent fash-
ion. There are four possible routes that the membrane could 
take: (a) it could traffic directly to the site of transcellular 
migration; (b) it could recycle constitutively back to the en-
dothelial cell border and diff  use along the surface to the site 
of transcellular migration; (c) it could recycle to the apical 
surface and diff  use to the site of transcellular migration; and 
(d) it could recycle to the cell border or the apical surface, 
and then be reendocytosed and targeted (by a non-LBRC 
pathway) to the site of transcellular migration. 
  The data in   Figs. 5   and   7   clearly show that depolymeriza-
tion of microtubules blocks the accumulation of LBRC 
membrane around the leukocyte (and hence blocks transmi-
gration.) We have shown that the same treatment has no ef-
fect on constitutive recycling of LBRC membrane back to 
the cell border (  Mamdouh et al., 2008  ). Furthermore, depo-
lymerization of microtubules under the conditions we use 
has no eff  ect on endocytosis. Finally, we have shown that 
the LBRC is distinct from typical recycling endosomes and 
caveolae (  Mamdouh et al., 2003  ). If membrane from the 
LBRC were getting to the site of transcellular migration by 
any of routes b–d, it would not have been blocked by DCN 
and it would have accumulated under the leukocyte to form 
a ring in the experiments of   Figs. 5   and   7  . Therefore, our 
data rule out any other possibility except direct targeting to 
the site of transcellular migration. 
  In agreement with previous reports of transcellular migration 
(  Carman and Springer, 2004  ;   Yang et al., 2005  ;   Millán et al., 
2006  ;   Carman et al., 2007  ), we found enrichment of ICAM-1 
and JAM-A, and the absence of VE-cadherin, at the site of leu-
kocyte migration (  Fig. 1  ). We found, as reported in those other 
transcellular models, that uniformly expressed ICAM-1 on the 
luminal surface of HUVECs redistributed during leukocyte 
transcellular migration and was concentrated at the site of diape-
desis. We also showed that ICAM-1 was enriched in the mem-
brane channel that surrounded the crossing monocyte as it went 
through the endothelial cell body (  Fig. 1  ). However, for trans-
cellular migration, as for paracellular migration, we (  Mamdouh 
et al., 2008  ) and others (  Shaw et al., 2004  ;   Yang et al., 2005  ) do 
not observe the docking structures or transmigratory cups formed 
by projections of ICAM-1 above the plane of the endothelial 
cell membrane (  Barreiro et al., 2002  ;   Carman and Springer, 
2004  ). Even if the XZ projections shown in   Figs. 4   and   7  , for 
example, are summed across the entire width of the leukocyte, 
the ICAM and PECAM staining does not rise signifi  cantly above 
the surface of the endothelial cell (unpublished data). Previous 
documentation of PECAM at the site of transcellular migration 
ring of ICAM-1 and virtually none with a ring of recycled 
PECAM only (  Fig. 7  ). These data demonstrate that micro-
tubule depolymerization blocks recycling of the LBRC and 
transcellular migration. These results show that ICAM-1 
enrichment is an upstream event that is perhaps necessary 
but certainly not suffi   cient for transcellular migration. 
  DISCUSSION 
  Previous studies performed in vivo and in vitro have shown 
that leukocytes are capable of crossing the endothelium by 
both para- and transcellular routes (  Muller, 2001  ;   Ley et al., 
2007  ;   Carman and Springer, 2008  ). At fi   rst glance, these 
routes appear quite distinct. However, the results we report 
in this paper show that they have much more in common 
than originally thought. In both cases, the leukocyte under-
going transmigration is surrounded by membrane recruited from 
the LBRC. This membrane compartment contains PECAM, 
JAM-A, and CD99, but appears to exclude VE-cadherin 
(  Figs.   1 and   3  ). When the LBRC membrane surrounds leu-
kocytes undergoing transcellular migration, it provides them 
with a “parajunctional junction,” a channel of membrane lined 
with the molecules it needs to interact with as it crosses the 
endothelial cell. Traffi   cking of LBRC membrane for both 
para- and transcellular migration requires intact microtubules 
(  Fig. 5  ), which might be expected for membrane vesicles 
moving rapidly over relatively long distances. Both para- and 
    Figure 6.     Blocking PECAM or CD99 blocks transcellular migration.   
Transmigration assays conducted in the presence of antibodies against 
PECAM, CD99, JAM-A, or VE-cadherin and analyzed as described in Materi-
als and methods. The mAb against VE-cadherin was used as a negative con-
trol, because it has been shown not to inhibit transmigration (  Muller et al., 
1993  ;   Schenkel et al., 2002  ). Leukocytes were scored as nontransmigrated, 
transmigrated paracellularly (Para), or transmigrated transcellularly (Trans). 
Under these conditions,     80% of control leukocytes transmigrated:    50% 
paracellularly and 30% transcellularly. Antibodies against PECAM and CD99 
blocked both para- and transcellular diapedesis signifi  cantly, whereas anti-
body against JAM-A had no effect. Data are means ± SEM from three sepa-
rate experiments in which >250 leukocytes were counted for each 
condition. *, P < 10     5   compared with VE-cadherin control or JAM-A.    JEM VOL. 206, November 23, 2009 
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a previous study from   Millán et al.   (  2006  ), we generally did 
not see any enrichment in caveolin-1 at the site of diapede-
sis, which is consistent with the fi  nding that the membrane 
of the LBRC does not contain caveolin-1 (  Mamdouh et al., 
2003  ). We did observe transcellular migration events in 
which caveolin-1 staining appeared to be modestly enriched 
has been inconsistent, even from the same group (  Carman and 
Springer, 2004  ;   Carman et al., 2007  ). However, we clearly see 
PECAM enrichment (  Fig. 1  ) and document that the source of 
that PECAM is the LBRC (  Fig. 4  ). 
  Similar to the observations of Carman et al. (  Carman 
and Springer, 2004  ;   Carman et al., 2007  ) but in contrast to 
    Figure 7.     Disruption of microtubules prevents targeted traffi  cking of LBRC but not ICAM-1 enrichment.   (a) Endothelial monolayers treated 
as in   Fig. 6   were used in experiments to promote transcellular migration. Monolayers were stained to demonstrate LBRC recycling (Rec PECAM-1; red 
in merge), ICAM-1 (green in merge), or DNA (blue in merge). Control cells show enrichment of ICAM-1 around monocytes migrating transcellularly 
(orthogonal projection) as well as membrane traffi  cking from the LBRC, as seen in the merge. In the orthogonal images, the thin white line underlies 
the endothelial monolayer. In DCN-treated monolayers, the monocyte is still fi  rmly attached to the endothelial surface surrounded by a zone of en-
richment of ICAM-1. However, depolymerization of microtubules prevents targeted traffi  cking from the LBRC, and the monocyte cannot transmigrate. 
These images are representative of several hundred leukocyte–endothelial cell interactions viewed on 50 separate monolayers in fi  ve independent ex-
periments. Bars, 10 μm. (b) Quantifi  cation of data shown in panel a. Leukocytes making productive contact with the endothelial monolayer, as defi  ned 
by being surrounded by a ring of enrichment of either ICAM-1 or recycled PECAM, or both, were enumerated. Data are expressed as the percentage of 
leukocytes surrounded only by recycled PECAM, only by ICAM-1, or by both recycled PECAM and ICAM-1. Data are means ± SEM. p-values are highly 
signifi  cant: 1, P = 1.9 × 10     5  ; 2, P = 7.4 × 10     13  ; 3, P = 5.86 × 10     7  ; 4, P = 7.07 × 10     10 .   2804 Trans- and paracellular migration share common mechanism   | Mamdouh et al. 
barrier, migrating across the cell at a thin point may be easier, 
as seen in cerebral infl  ammation (  Lossinsky and Shivers, 2004  ; 
  Wolburg et al., 2005  ). However, the postcapillary venules that 
are the sites of most infl  ammatory diapedesis have very leaky 
junctions. In fact, they are specialized for permeability, be-
cause this is the site of fl  uid reuptake from the interstitium 
(  Simionescu and Simionescu, 1983  ). Endothelial cells in cul-
ture, where transcellular migration has been best demonstrated, 
form a monolayer of low electrical resistance even under the 
most optimal culture conditions (  Furie et al., 1984  ). 
  We hypothesize that at least for low-resistance endothelia, 
transcellular migration may occur when leukocytes are highly 
and/or directly activated. The fi  rst indisputable evidence of 
neutrophil transcellular migration in vivo came from studies in 
which emigration was stimulated by direct injection of fMLP, 
a PMN chemoattractant and     2 integrin activator, into the 
skin of guinea pigs (  Feng et al., 1998  ). The authors presented 
a collection of electron microscope serial sections in which 
PMNs were shown to pass entirely across an endothelial cell 
without ever contacting a recognizable junction (  Feng et al., 
1998  ). Although the absolute frequency of transcellular migra-
tion was not addressed in this study, it demonstrated that tran-
scellular migration was possible in vivo. The published in vitro 
studies of transcellular migration used MCP-1, platelet-acti-
vating factor, or stromal cell–derived factor 1 (CXCL12) to 
stimulate migration of monocytes, neutrophils, and T cells, 
respectively (  Carman and Springer, 2004  ), or used mitogen-
activated T lymphoblasts (  Millán et al., 2006  ;   Carman and 
Springer, 2008  ). Furthermore, these agents were added to the 
apical side of the endothelium, where they would activate leu-
kocytes but not provide a chemotactic gradient. In our stan-
dard TEM assay system, paracellular migration predominates 
and transcellular migration is almost never seen across cyto-
kine-activated HUVECs. However, when we applied che-
mokine or chemoattractant in the present study, 10–30% of 
leukocytes migrated transcellularly, similar to levels observed 
in the published studies (  Carman and Springer, 2004  ;   Yang 
et al., 2005  ;   Millán et al., 2006  ;   Carman et al., 2007  ). As ob-
served by the authors of those studies, the rate of transcellular 
migration may be underestimated because we only scored leu-
kocytes crossing endothelial cells >3 μm from the junction as 
transcellular events. Many of the studies that provide evidence 
for transcellular migration in vivo often show electron micro-
graphs of leukocytes passing through the cell within a mi-
crometer or two of an intact endothelial junction (  Lossinsky 
and Shivers, 2004  ;   Wolburg et al., 2005  ). This is exactly where 
the LBRC is situated and would put it in a prime location for 
its role in promoting trans- as well as paracellular migration. 
  Transcellular migration is also dependent on PECAM and 
CD99 (  Fig. 6  ). Because expression of PECAM and CD99 on 
the endothelial cell surface is essentially restricted to cell bor-
ders, this was not necessarily expected. Homophilic interac-
tion between leukocyte PECAM and endothelial PECAM 
appears to be the trigger for targeted recycling of the LBRC 
during paracellular migration of neutrophils and monocytes 
(  Mamdouh et al., 2003  ;   Mamdouh et al., 2008  ). Polyclonally 
above background in the vicinity of the transmigration pore 
(  Fig. 2  ). However, when these cells were costained with 
anti-PECAM, it was clear that the caveolin-1 staining (pre-
sumably marking caveolae) was peripheral to the ring of 
LBRC membrane and not fused with it. The observations 
of   Millán et al.   (  2006  ) were made on lymphoblasts, whereas 
we report on PMNs and monocytes; however, the observa-
tions of Carman et al. (  Carman and Springer, 2004  ;   Carman 
et al., 2007  ) were also made on lymphoblasts. Caveolae and 
other organelles have low diff  usion rates and can have mem-
brane and cytoskeletal tethers, which could impair their 
ability to be displaced by a migrating leukocyte. This could 
give the impression that they are relatively enriched around 
the transmigration pore. Because we did not attempt to de-
tect them, we cannot exclude the possibility that membrane 
from other subcellular compartments, including the apical 
surface, is involved in transcellular migration. However, our 
data demonstrate that the LBRC is a critical functional 
component of the transcellular channel. 
  The apparent lack of VE-cadherin in the LBRC could 
explain an old observation made during paracellular migra-
tion: When a leukocyte crosses the endothelial border, VE-
cadherin at the border appears to move out of the way (  Allport 
et al., 2000  ;   Shaw et al., 2001  ). As the transmigrating leuko-
cyte is surrounded by membrane coming from the LBRC, 
VE-cadherin at the cell border may be either diluted or pushed 
out of the way. VE-cadherin has been shown to undergo en-
docytosis via a clathrin-dependent pathway (  Xiao et al., 2005  ); 
it is apparently not internalized into the LBRC. 
  We grow our endothelial monolayers on hydrated fi  brillar 
collagen gels rather than directly on glass or plastic to allow 
them to form a physiological basal lamina, which is important 
for endothelial monolayer stability and polarity. This precludes 
the use of shear fl  ow in our transmigration studies. However, 
like paracellular migration (  Mamdouh et al., 2008  ), transcellu-
lar migration is not noticeably aff  ected by shear fl  ow (  Carman 
et al., 2007  ). 
  Using transfected cell lines,   Yang et al.   (  2005  ) showed that 
overexpression of ICAM-1 promoted transcellular migration, 
implicating a role for ICAM-1 in this process. We show that 
disruption of microtubules had no eff  ect on ICAM-1 enrich-
ment around adherent leukocytes (  Fig. 7  ), even though it 
blocked targeted recycling from the LBRC (  Figs. 5   and   7  ) and 
both para- and transcellular migration (  Figs. 5   and   7  ). There-
fore, although enrichment of ICAM-1 may help promote 
transmigration and may even be a necessary prerequisite, it is 
not suffi   cient to promote transmigration in the absence of a 
functional LBRC. 
  Paracellular migration involves an elaborate series of roll-
ing, adhesion, and locomotion events designed to bring the 
leukocyte close to the endothelial border. Transcellular migra-
tion appears to use the same initial steps. However, for some 
reason the leukocytes migrate through the cell rather than at 
the border.   Carman and Springer   (  2008  ) speculated that the 
leukocytes take the path of least resistance across the endothe-
lium. If junctions are very tight, e.g., as in the blood–brain JEM VOL. 206, November 23, 2009 
Article
2805
homophilic adhesion molecules such as PECAM, CD99, and 
JAM-A tightly engage leukocytes as they pass through the 
endothelial cell could allow leukocyte passage without plasma 
leakage. The LBRC could provide such a route. 
    Carman et al.  ( 2007  ) showed leukocytes appearing to probe 
the endothelial surface with lamellipodia (podosomes), often 
deeply invaginating the surface of the endothelial cell. They 
were highly enriched for actin fi  laments (  Feng et al., 1998  ; 
  Carman et al., 2007  ), which were required for their function 
(  Carman et al., 2007  ). Actin polymerization and lamellapodia 
formation are events triggered in leukocytes by integrin activa-
tion, so prominent podosomes in cells migrating transcellularly 
could be manifestations of high levels of leukocyte activation. 
The podosomes were hypothesized to initiate the formation of 
the transcellular channel. In previous studies, such podosomes 
were observed invaginating the endothelial surface away from 
the junctions even under conditions where leukocytes crossed 
at the cell borders (  Furie et al., 1987  ;   Migliorisi et al., 1987  ), as 
well as under conditions where leukocytes are blocked in their 
attempts to cross at the junctions (Fig. 4 a in   Liao et al., 1995  ). 
These lamellapodia may be a general mechanism for leuko-
cytes to crawl across the endothelial surface. However, if they 
have a role in promoting transmigration, it is conceivable that 
they signal the recruitment of LBRC membrane to the leuko-
cytes when they are at the cell borders as well as when they are 
not. In this case, the mechanisms of para- and transcellular mi-
gration would have even more in common. 
  At least one potential mechanistic diff  erence  between 
para- and transcellular migration remains. Because the LBRC 
is connected to the lateral endothelial cell surface at the cell 
borders, fusion of the LBRC membrane with the plasma 
membrane is not necessarily required to bring the LBRC in 
contact with the leukocyte for paracellular TEM. On the 
other hand, to bring this membrane compartment in contact 
with the leukocyte on the apical surface for transcellular mi-
gration would require membrane fusion. In fact,   Carman et al.   
(  2007  ) provide evidence that membrane fusion is required for 
transcellular migration. However, because the LBRC vesicles 
are connected to each other (  Mamdouh et al., 2003  ) rather 
than multiple fusion events involving dozens or hundreds of 
vesicles, the entire surface area of the LBRC could be brought 
to surround the leukocyte with perhaps only two fusion events 
necessary: one at the apical surface and one at the basal surface 
of the endothelial cell. 
  In conclusion, we report for the fi  rst time that leukocyte 
transcellular diapedesis requires targeted traffi   cking of LBRC 
membrane, which contains PECAM-1, JAM-A, and CD99, 
but not VE-cadherin, to surround the leukocyte. Antibodies 
that block PECAM and CD99 function inhibit transcellular 
migration. We also show that transcellular diapedesis and 
LBRC traffi   cking are microtubule dependent, but that ICAM-1 
clustering around the crossing leukocyte is an upstream event 
that is independent of microtubules and LBRC recycling. 
Our data demonstrate that trans- and paracellular diapedesis 
involve similar mechanisms and may, in fact, have more 
mechanistic similarities than diff  erences. If this is true, it is 
activated lymphocytes, whose migration is PECAM indepen-
dent, still require targeted recycling of the LBRC for paracel-
lular migration (  Mamdouh et al., 2008  ). We hypothesize that 
these activated lymphocytes are capable of sending a signal to 
the endothelial cells to recruit the LBRC that bypasses the 
PECAM requirement (  Mamdouh et al., 2008  ). It is reason-
able to expect that activated myeloid cells migrating transcel-
lularly transmit a similar signal because there would be no 
PECAM to interact with, rendering transcellular migration 
PECAM (and CD99) independent. This hypothesis may still 
hold true for the initial recruitment of LBRC membrane. 
However, once transcellular migration starts, it is apparently 
PECAM and CD99 dependent. The fact that PECAM and 
CD99 are both in the LBRC and are required for both para- 
and transcellular migration raises the question of whether 
PECAM regulates a step in transcellular migration before the 
CD99-dependent step, as it does in paracellular migration 
(  Schenkel et al., 2002  ;   Lou et al., 2007  ). This is a goal for fu-
ture research. Our immuno-EM and fl  uorescence quenching 
experiments show that PECAM and CD99 share the same 
distribution, but give no quantitative information on how 
they may be spatially organized along the cell border. 
  We and others fi  nd no role for JAM-A in the paracellular 
transmigration of human PMNs or monocytes (  Fig. 6  ;   Liu 
et al., 2000  ;   Schenkel et al., 2004  ;   Shaw et al., 2004  ). Although 
JAM-A appears to be in the LBRC, we are unable to block 
transcellular migration using the same mAb (  Fig. 6  ). The role 
for JAM-A in leukocyte emigration has been reported to be 
through interaction with LFA-1 on the leukocyte when JAM-A 
is on the apical surface of the endothelial cells (  Ostermann 
et al., 2002  ). Under our culture conditions, JAM-A remains 
at the cell border or in the LBRC. Furthermore, interactions 
with JAM-A on the apical surface would be more relevant to 
the adhesion step that precedes transmigration than to the 
transmigration step itself. 
  How is the LBRC, a membrane compartment that is 
contiguous with the lateral borders of endothelial cells, redi-
rected to the site of transcellular migration? This is not clear 
and is obviously the subject for future work. However, we 
speculate that a signal from the leukocyte may trigger it, per-
haps the same signal that is given at the cell border to recruit 
the LBRC to promote paracellular migration. This might oc-
cur if the leukocyte were so activated that it transmitted the 
signal prematurely before reaching the lateral border. The 
fact that transcellular migration is more common among 
highly and directly activated leukocytes is consistent with this 
hypothesis. The clustering of ICAM-1 that precedes LBRC 
recruitment suggests that it might be involved in transmitting 
this signal through interactions with the leukocyte. Transcel-
lular migration may also occur if the leukocyte has diffi   culty 
reaching the junction, such as in cells in which CD11b is 
nonfunctional (  Schenkel et al., 2004  ) or defi  cient (  Phillipson 
et al., 2006  ) or in cells that are unable to polarize (  Gerard 
et al., 2009  ), or in vasculature in which the junction is partic-
ularly tight, such as the blood–brain barrier (  Lossinsky and 
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  In some experiments, microtubules were depolymerized as previously 
described using 10 μM DCN under conditions that did not aff  ect the dis-
tribution of PECAM, ICAM-1, or VE-cadherin, or otherwise noticeably 
perturb the cells (  Mamdouh et al., 2008  ). This drug was washed out be-
fore addition of leukocytes. Control experiments (not depicted;   Mamdouh 
et al., 2008  ) demonstrated that there was no carryover of DCN to aff  ect 
leukocyte microtubules. 
  Immunofl  uorescence microscopy.     To visualize the distribution of adhe-
sion molecules during leukocyte transmigration, leukocytes were allowed to 
transmigrate for 10 min across HUVEC monolayers as described, and were 
then washed and fi  xed in freshly prepared 2% paraformaldehyde. Specifi  c 
antibodies for each adhesion molecule were used either directly conjugated 
to Alexa Fluor dyes or detected with a fl  uorescent secondary antibody. To 
label actin, cells were permeabilized after fi  xation with 0.2% Triton X-100 
(Sigma-Aldrich) for 10 min and incubated with Alexa Fluor 488– or Alexa 
Fluor 546–labeled phalloidin for 10 min at room temperature. 
  Images were collected using a confocal inverted microscope (Axiovert 
100M) equipped with an LSM 510 laser scanning unit and a 63 × 1.4 or a 
100 × 1.46 NA plan Apochromat objective (all from Carl Zeiss, Inc.). The 
LSM 510 was equipped with a 25-mW argon laser emitting at 488 nm, a 
1-mW helium/neon laser emitting at 543 nm, a 5-mW helium/neon laser 
emitting at 633 nm, and a UV laser emitting at 405 nm. Image processing 
and quantifi  cation were performed using image processing software (Meta-
Morph; MDS Analytical Technologies). Alternatively, stacks of optical sec-
tions through the specimen were acquired on a restoration workstation 
(Delta Vision 3D; Applied Precision) equipped with an inverted microscope 
(model IX70; Olympus) using a 100× objective lens. Images were decon-
volved using SoftWorx software (Applied Precision). The fi  gures show either 
representative optical sections through the region of interest or projections of 
the whole stack using the maximum intensity method. 
  Quantifi  cation of trans- and paracellular diapedesis.     10 μl of 20 ng/ml 
MCP-1 was injected into the collagen bearing TNF-activated HUVECs be-
fore adding 2 × 10  5   PBMCs in cold M199 containing 0.1% human serum al-
bumin. Cells were allowed to settle for 15 min on ice and warmed for 10 min 
at 37° in a CO  2   incubator. Cells were washed, fi  xed in 2% paraformaldehyde, 
and stained for VE-cadherin and actin. Fixed samples were examined by con-
focal and wide-fi  eld microscopy. Image stacks obtained by confocal micros-
copy and deconvolved images acquired by wild-fi  eld microscopy were analyzed 
for quantifi  cation of diapedesis. Monocytes crossing endothelial cells >3 μm 
from the junctions were scored as transcellular diapedesis. Total monocytes as-
sociated with endothelial cells in each fi  eld (i.e., monocytes on top and under 
HUVECs, plus those in the act of diapedesis) were counted. Percent TEM was 
calculated by dividing the number of cells in the act of diapedesis by the total 
number of monocytes in each fi  eld. 
  In experiments to determine whether blockade of PECAM, CD99, or 
JAM-A would aff  ect transcellular migration, experiments were performed as de-
scribed, except that leukocytes were mixed with antibodies against those mole-
cules or VE-cadherin (as a negative control) before adding them to the endothelial 
monolayers. Transmigration was allowed to proceed for 30 min, and the mono-
layers were fi  xed and processed as described. Alexa Fluor 488–conjugated sec-
ondary antibodies were used to detect the cell junctions. Actin was visualized 
with Alexa Fluor 546–phalloidin. Leukocytes found directly below or crossing at 
cell borders were scored as paracellular migration events; those detected under or 
in the act of crossing the endothelial cell body >3 μm from the junctions were 
scored as transcellular migration events. Percent TEM was calculated as the num-
ber of transmigrated monocytes divided by the total monocytes in the fi  eld. 
  immuno-EM.     P1.1, 1H29A, hec1, and hec2 IgGs were conjugated to HRP 
as previously described (  Mamdouh et al., 2003  ) . HUVEC monolayers plated 
on fi  bronectin-coated coverslip dishes were incubated with each of the HRP-
conjugated antibodies separately for 1 h at 37°C or with the equivalent con-
centration of free HRP (5.5 μg/ml). Cells were rinsed in PBS and fi  xed in 
glutaraldehyde (EM Sciences) in 0.1 M sodium cacodylate buff  er for 15 min. 
conceivable that many transmigration events that occur close 
to endothelial borders may be partially transcellular and par-
tially paracellular, with leukocytes moving between and 
through endothelial cells depending on the rapidity and ease 
of LBRC recruitment. In that case, the distinction between 
trans- and paracellular migration would break down, and the 
major question for future research in this area would be, what 
recruits the LBRC to the leukocyte? 
  MATERIALS AND METHODS 
  Reagents.     Hybridomas producing the mAbs R6.5 (anti–ICAM-1) and 
OKM1 (anti-CD11b) were obtained from American Type Culture Collec-
tion. The mAbs hec1 (anti–VE-cadherin) and hec2 (anti-CD99) were pro-
duced from hybridomas generated in the laboratory, as described previously 
(  Muller et al., 1989  ). P1.1 (nonblocking anti–PECAM-1 mAb) was column 
purifi  ed on protein A–Sepharose (GE Healthcare) from ascites provided by 
P.J. Newman (BloodCenter of Wisconsin, Milwaukee, WI). Fab fragments 
of P1.1 were cut using papain (Thermo Fisher Scientifi  c), followed by col-
umn purifi  cation on protein A–Sepharose. Purity of Fab fragments was con-
fi   rmed by SDS-PAGE. 1H29A (anti–JAM-A) was purifi   ed on protein 
A–Sepharose from ascites provided by C. Parkos (Emory University, At-
lanta, GA). Rabbit anti-PECAM antibody 177 was produced and purifi  ed as 
previously described (  Lou et al., 2007  ). Rabbit anti–caveolin-1 antibody was 
purchased from BD. Unlabeled and rhodamine-conjugated goat anti–mouse 
F(ab    )  2   antibodies used for recycling experiments of PECAM were pur-
chased from Jackson ImmunoResearch Laboratories. Antibodies for immu-
nofl  uorescence were coupled to Alexa Fluor 488, Alexa Fluor 546, or Alexa 
Fluor 633 according to the manufacturer’s protocol (Invitrogen). Alexa 
Fluor 488–phalloidin and Alexa Fluor 546–phalloidin were purchased from 
Invitrogen. DCN was purchased from EMD. DAB was purchased from 
Sigma-Aldrich. 
  Cells.     HUVECs were isolated from fresh human umbilical cords as previ-
ously described (  Muller et al., 1989  ) and grown in M199 medium (Invitro-
gen) supplemented with 20% heat-inactivated normal human serum and 
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Cells were washed and exposed to a mixture of DAB and H  2  O  2   according to 
the method of   Graham and Karnovsky   (  1966  ). The cells were postfi  xed in 4% 
glutaraldehyde and embedded in plastic, and en face sections were cut and ex-
amined on an electron microscope (JSM 100CX II; JEOL). 
  Fluorescence quenching experiments.     These experiments were performed 
as previously described (  Ghosh et al., 1998  ;   Lampson et al., 2001  ). In brief, en-
dothelial cells grown on coverslip dishes were incubated with 20 μg/ml of Al-
exa Fluor 488–conjugated anti-CD99 mAb and 20 μg/ml of HRP-conjugated 
anti-PECAM mAb for 1 h at 37° to allow ample time for delivery to the 
LBRC. In control experiments, chromophores were reversed or HRP-trans-
ferrin (the gift of T. McGraw, Weill Cornell Medical College, New York, 
NY) was used to label a defi  ned endocytic compartment in place of the HRP–
anti-PECAM or HRP–anti-CD99. Cells were chilled, washed extensively, 
and incubated on ice for 30 min in darkness with 250 μg/ml DAB and 0.0025% 
H  2  O  2  . DAB diff  uses into the cell and the HRP on the conjugated antibody 
catalyzes the oxidation of DAB in the presence of H  2  O  2  . Oxidized DAB reac-
tion product polymerizes and quenches the fl  uorescence of molecules in its vi-
cinity. Because the polymerized DAB precipitates locally and does not diff  use 
across membranes, it will only quench fl  uorescence of the Alexa Fluor–labeled 
mAb if the antibodies (and hence the antigens) are in the same compartment. 
  Statistics.     All data were analyzed by pairwise comparison using a two-tailed 
  t   test assuming unequal variances, with the Bonferroni correction for multi-
ple comparisons as appropriate. 
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